Live from the NIH registry
Studies recruiting near Santa Maria right now
Top 25 of 95 recruiting studies, sorted by proximity — each links to its official registry page
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Cardiovascular Health
N/A
Interventional 6,618 participants sought
California Polytechnic State University — San Luis Obispo, California (27.1 mi)
· Sponsor: JHSPH Center for Clinical Trials
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Mission Hills, California (17.1 mi)
· Sponsor: GlaxoSmithKline
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: Children's Oncology Group
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Wake Forest University Health Sciences
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Canadian Cancer Trials Group
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: NRG Oncology
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: NRG Oncology
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,200 participants sought
GSK Investigational Site — Santa Maria, California (1.4 mi)
· Sponsor: GlaxoSmithKline
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Santa Maria, California (1.4 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Heart Failure
Phase 2
Interventional 620 participants sought
Comprehensive Cardiovascular Care — Santa Maria, California (1.4 mi)
· Sponsor: Pfizer
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Sansum Clinic — Solvang, California (29.1 mi)
· Sponsor: Stemline Therapeutics, Inc.
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: SWOG Cancer Research Network
Creatine Supplementation At Simulated Altitude
Exercise Performance
N/A
Interventional 60 participants sought
California Polytechnic State University — San Luis Obispo, California (27.1 mi)
· Sponsor: California Polytechnic State University-San Luis Obispo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers
Metastatic Pancreatic Adenocarcinoma
N/A
Interventional 136 participants sought
City of Hope Mission Hills — Mission Hills, California (17.1 mi)
· Sponsor: City of Hope Medical Center
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
UCLA Hematology/Oncology - San Luis Obispo — San Luis Obispo, California (27.1 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: NRG Oncology
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: National Cancer Institute LAO
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Central Line Associated Blood Stream Infections (CLABSI)
N/A
Interventional 17,800 participants sought
Providence Holy Cross Medical Center — Mission Hills, California (17.1 mi)
· Sponsor: Swedish Medical Center
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
Burnout, Burnout Syndrome
N/A
Interventional 203 participants sought
Santa Maria VA Clinic, VA Greater Los Angeles Healthcare System — Santa Maria, California (1.4 mi)
· Sponsor: VA Greater Los Angeles Healthcare System
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Mucositis, Nephrotoxicity
Phase 2
Interventional 120 participants sought
Central Coast Medical Oncology — Santa Maria, California (1.4 mi)
· Sponsor: Matrix Biomed, Inc.